Global Follicle Stimulating Hormone Market by Type (Recombinant FSH, Urinary FSH), By Application (Infertility Treatment, Assisted Reproductive Technology) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
Up Market Research published a new report titled “Follicle Stimulating Hormone Market research report which is segmented by Types (Recombinant FSH, Urinary FSH), By Applications (Infertility Treatment, Assisted Reproductive Technology), By Players/Companies Merck Serono, MSD, IBSA, Ferring, Livzon, Techwell, GenSci, Gedeon Richter, Teva, Merck Serono”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Scope
| Report Attributes | Report Details |
| Report Title | Follicle Stimulating Hormone Market Research Report |
| By Type | Recombinant FSH, Urinary FSH |
| By Application | Infertility Treatment, Assisted Reproductive Technology |
| By Companies | Merck Serono, MSD, IBSA, Ferring, Livzon, Techwell, GenSci, Gedeon Richter, Teva, Merck Serono |
| Regions Covered | North America, Europe, APAC, Latin America, MEA |
| Base Year | 2020 |
| Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
| Forecast Year | 2028 |
| Number of Pages | 209 |
| Number of Tables & Figures | 147 |
| Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Follicle Stimulating Hormone Market Report Segments:
The market is segmented by Type Recombinant FSH, Urinary FSH and By Application Infertility Treatment, Assisted Reproductive Technology.
Some of the companies that are profiled in this report are:
- Merck Serono
- MSD
- IBSA
- Ferring
- Livzon
- Techwell
- GenSci
- Gedeon Richter
- Teva
- Merck Serono
Follicle Stimulating Hormone Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Follicle Stimulating Hormone Market
Overview of the regional outlook of the Follicle Stimulating Hormone Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Follicle Stimulating Hormone Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Follicle Stimulating Hormone Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
- By Type:
1. Recombinant FSH
2. Urinary FSH
7. By Application:1. Infertility Treatment
2. Assisted Reproductive Technology
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Follicle Stimulating Hormone Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Follicle Stimulating Hormone Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Follicle Stimulating Hormone Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Follicle Stimulating Hormone Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Follicle Stimulating Hormone Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Follicle Stimulating Hormone Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Follicle Stimulating Hormone Market Size & Forecast, 2018-2028
4.5.1 Follicle Stimulating Hormone Market Size and Y-o-Y Growth
4.5.2 Follicle Stimulating Hormone Market Absolute $ Opportunity
Chapter 5 Global Follicle Stimulating Hormone Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Follicle Stimulating Hormone Market Size Forecast by Type
5.2.1 Recombinant FSH
5.2.2 Urinary FSH
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Follicle Stimulating Hormone Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Follicle Stimulating Hormone Market Size Forecast by Applications
6.2.1 Infertility Treatment
6.2.2 Assisted Reproductive Technology
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Follicle Stimulating Hormone Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Follicle Stimulating Hormone Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Follicle Stimulating Hormone Analysis and Forecast
9.1 Introduction
9.2 North America Follicle Stimulating Hormone Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Follicle Stimulating Hormone Market Size Forecast by Type
9.6.1 Recombinant FSH
9.6.2 Urinary FSH
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Follicle Stimulating Hormone Market Size Forecast by Applications
9.10.1 Infertility Treatment
9.10.2 Assisted Reproductive Technology
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Follicle Stimulating Hormone Analysis and Forecast
10.1 Introduction
10.2 Europe Follicle Stimulating Hormone Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Follicle Stimulating Hormone Market Size Forecast by Type
10.6.1 Recombinant FSH
10.6.2 Urinary FSH
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Follicle Stimulating Hormone Market Size Forecast by Applications
10.10.1 Infertility Treatment
10.10.2 Assisted Reproductive Technology
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Follicle Stimulating Hormone Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Follicle Stimulating Hormone Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Follicle Stimulating Hormone Market Size Forecast by Type
11.6.1 Recombinant FSH
11.6.2 Urinary FSH
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Follicle Stimulating Hormone Market Size Forecast by Applications
11.10.1 Infertility Treatment
11.10.2 Assisted Reproductive Technology
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Follicle Stimulating Hormone Analysis and Forecast
12.1 Introduction
12.2 Latin America Follicle Stimulating Hormone Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Follicle Stimulating Hormone Market Size Forecast by Type
12.6.1 Recombinant FSH
12.6.2 Urinary FSH
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Follicle Stimulating Hormone Market Size Forecast by Applications
12.10.1 Infertility Treatment
12.10.2 Assisted Reproductive Technology
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Follicle Stimulating Hormone Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Follicle Stimulating Hormone Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Follicle Stimulating Hormone Market Size Forecast by Type
13.6.1 Recombinant FSH
13.6.2 Urinary FSH
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Follicle Stimulating Hormone Market Size Forecast by Applications
13.10.1 Infertility Treatment
13.10.2 Assisted Reproductive Technology
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Follicle Stimulating Hormone Market: Competitive Dashboard
14.2 Global Follicle Stimulating Hormone Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck Serono
14.3.2 MSD
14.3.3 IBSA
14.3.4 Ferring
14.3.5 Livzon
14.3.6 Techwell
14.3.7 GenSci
14.3.8 Gedeon Richter
14.3.9 Teva
14.3.10 Merck Serono
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Follicle Stimulating Hormone Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Follicle Stimulating Hormone Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Follicle Stimulating Hormone Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Follicle Stimulating Hormone Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Follicle Stimulating Hormone Market Size & Forecast, 2018-2028
4.5.1 Follicle Stimulating Hormone Market Size and Y-o-Y Growth
4.5.2 Follicle Stimulating Hormone Market Absolute $ Opportunity
Chapter 5 Global Follicle Stimulating Hormone Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Follicle Stimulating Hormone Market Size Forecast by Type
5.2.1 Recombinant FSH
5.2.2 Urinary FSH
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Follicle Stimulating Hormone Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Follicle Stimulating Hormone Market Size Forecast by Applications
6.2.1 Infertility Treatment
6.2.2 Assisted Reproductive Technology
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Follicle Stimulating Hormone Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Follicle Stimulating Hormone Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Follicle Stimulating Hormone Analysis and Forecast
9.1 Introduction
9.2 North America Follicle Stimulating Hormone Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Follicle Stimulating Hormone Market Size Forecast by Type
9.6.1 Recombinant FSH
9.6.2 Urinary FSH
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Follicle Stimulating Hormone Market Size Forecast by Applications
9.10.1 Infertility Treatment
9.10.2 Assisted Reproductive Technology
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Follicle Stimulating Hormone Analysis and Forecast
10.1 Introduction
10.2 Europe Follicle Stimulating Hormone Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Follicle Stimulating Hormone Market Size Forecast by Type
10.6.1 Recombinant FSH
10.6.2 Urinary FSH
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Follicle Stimulating Hormone Market Size Forecast by Applications
10.10.1 Infertility Treatment
10.10.2 Assisted Reproductive Technology
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Follicle Stimulating Hormone Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Follicle Stimulating Hormone Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Follicle Stimulating Hormone Market Size Forecast by Type
11.6.1 Recombinant FSH
11.6.2 Urinary FSH
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Follicle Stimulating Hormone Market Size Forecast by Applications
11.10.1 Infertility Treatment
11.10.2 Assisted Reproductive Technology
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Follicle Stimulating Hormone Analysis and Forecast
12.1 Introduction
12.2 Latin America Follicle Stimulating Hormone Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Follicle Stimulating Hormone Market Size Forecast by Type
12.6.1 Recombinant FSH
12.6.2 Urinary FSH
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Follicle Stimulating Hormone Market Size Forecast by Applications
12.10.1 Infertility Treatment
12.10.2 Assisted Reproductive Technology
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Follicle Stimulating Hormone Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Follicle Stimulating Hormone Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Follicle Stimulating Hormone Market Size Forecast by Type
13.6.1 Recombinant FSH
13.6.2 Urinary FSH
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Follicle Stimulating Hormone Market Size Forecast by Applications
13.10.1 Infertility Treatment
13.10.2 Assisted Reproductive Technology
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Follicle Stimulating Hormone Market: Competitive Dashboard
14.2 Global Follicle Stimulating Hormone Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck Serono
14.3.2 MSD
14.3.3 IBSA
14.3.4 Ferring
14.3.5 Livzon
14.3.6 Techwell
14.3.7 GenSci
14.3.8 Gedeon Richter
14.3.9 Teva
14.3.10 Merck Serono
Segments Covered in the Report
The global Follicle Stimulating Hormone market has been segmented based on
By Types
The global Follicle Stimulating Hormone market has been segmented based on
By Types
- Recombinant FSH
- Urinary FSH
- Infertility Treatment
- Assisted Reproductive Technology
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- Merck Serono
- MSD
- IBSA
- Ferring
- Livzon
- Techwell
- GenSci
- Gedeon Richter
- Teva
- Merck Serono
Our Clients
Related Reports
Some other reports from this category!
